[Federal Register Volume 89, Number 190 (Tuesday, October 1, 2024)]
[Notices]
[Pages 79922-79923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22477]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-24-1046; Docket No. CDC-2024-0074]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) Monitoring Activities. This data collection is designed to 
systematically collect information about implementation, including 
delivery of screening and follow-up clinical services, and outcomes of 
the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP).

DATES: CDC must receive written comments on or before December 2, 2024.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0074 by either of the following methods:
    <bullet> Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
    <bullet> Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: <a href="/cdn-cgi/l/email-protection#0d62606f4d6e696e236a627b"><span class="__cf_email__" data-cfemail="aec1c3cceecdcacd80c9c1d8">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) Monitoring Activities (OMB Control No. 0920-1046, Exp. 03/31/
2025)--Revision--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    CDC is requesting a Revision of the information collection titled 
National Breast and Cervical Cancer Early Detection Program (NBCCEDP) 
Monitoring Activities (OMB Control No. 0920-1046). The information 
collection consists of an annual NBCCEDP survey, baseline and annual 
clinic-level data collection, a quarterly program update (QPU) tool, a 
service delivery projection worksheet, and minimum data elements 
(MDEs). CDC proposes revisions to the Annual NBCCEDP Survey, clinic-
level data collection tool and QPU, and continued use of the service 
delivery projection worksheet and MDEs with no changes. The number of 
respondents will increase from 70 to 71 and the total estimated 
annualized burden will decrease from 1,220 hours to 1,162 hours.
    Breast and cervical cancers are prevalent among U.S. women. In 
2021, the U.S. experienced 272,454 new cases and 42,211 deaths as a 
result of breast cancer, as well as 12,536 new cases and 4,051 deaths 
as a result of cervical cancer. Evidence shows that deaths from both 
breast and cervical cancers can be avoided by increasing screening 
services--mammography, pap, and human papillomavirus (HPV) tests--among 
women. However, in 2021, approximately one quarter of adults were not 
up to date with breast and/or cervical cancer screening, and screening 
was underutilized among women who are under- or uninsured, have no 
regular source of healthcare, or who recently immigrated to the U.S. As 
a longstanding priority within chronic disease prevention, CDC focuses 
on increasing access to these cancer screenings, particularly among 
women who may be at increased risk.
    To improve access to cancer screening, Congress passed the Breast 
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 106-354), 
which directed CDC to create the National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP). The NBCCEDP currently provides 
funding to 71 recipients under ``Cancer Prevention and Control Programs 
for State, Territorial, and Tribal Organizations (DP22-2202).'' NBCCEDP 
awardees include states or their bona fide agents; U.S. territories; 
and tribes or tribal organizations. The purpose of NBCCEDP is to 
increase breast and cervical cancer screening rates among women 
residing within defined geographical locations (as determined by the 
funded program) who are at or below 250% of the federal poverty level; 
aged 50-75 years for breast cancer

[[Page 79923]]

services, and aged 21-64 years for cervical cancer services; and under- 
or uninsured.
    CDC proposes revisions to three of the previously approved 
information collection instruments:
    Annual NBCCEDP Survey--This instrument collects program-level 
information annually to monitor recipients' challenges, external 
funding sources, partnerships, and EBI implementation. The survey has 
been revised to include new survey questions to improve data quality 
for items related to partnership activities and recipients' 
requirements for patients' payments towards screening services, as well 
as the removal of a COVID-19 related question.
    Clinic-Level Data Collection Tool--This instrument collects clinic-
level data at baseline and annually to assess health system, clinic, 
and patient population characteristics; monitoring and quality 
improvement activities; EBI implementation; and baseline or annual 
screening rates. This tool has been revised to remove COVID-19 related 
variables and update response options for the measures used to report 
breast and cervical cancer screening rates.
    QPU--This instrument collects program-level data four times per 
year to monitor award spending, service delivery, staff vacancies, 
program challenges and successes, and TA needs. This instrument has 
been revised to include two optional open-ended items to allow 
recipients to provide context to reported service delivery and spending 
data only if needed.
    CDC proposes continued use of the remaining two information 
collections; Service Delivery Project Worksheet and the MDEs, which 
have not been changed. To maximize consistency in our routine data 
collections for the current NBCCEDP funding cycle, CDC has not revised 
NBCCEDP information collections to align with the Department of Health 
and Human Services (HHS)' current best practices for demographic 
questions related to sexual orientation and gender identity (SOGI) and 
race and ethnicity (R/E) at this time. However, CDC plans to revise 
information collections that include demographic items to align with 
HHS' SOGI and R/E guidelines for the next funding cycle beginning in 
2027.
    The proposed information collections will allow CDC to better gauge 
progress in meeting NBCCEDP program goals and monitor implementation 
activities, evaluate outcomes, and identify awardee technical 
assistance needs. In addition, findings will inform program improvement 
and help identify successful activities that need to be maintained, 
replicated, or expanded.
    OMB approval is requested for three years. CDC requests OMB 
approval for an estimated 1,162 annual burden hours. Participation is 
required for NBCCEDP awardees. There are no costs to respondents other 
than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees..............  Annual NBCCEDP                71               1           46/60              54
                                 Survey.
                                NBCCEDP Clinic-               71               6           40/60             284
                                 level
                                 Information
                                 Collection
                                 Instrument--Bre
                                 ast.
                                NBCCEDP Clinic-               71               6           40/60             284
                                 level
                                 Information
                                 Collection
                                 Instrument--Cer
                                 vical.
                                Quarterly                     71               4           22/60             151
                                 Program Update.
                                Service Delivery              71               1           29/60              34
                                 Projection
                                 Worksheet.
                                MDEs............              71               2          150/60             355
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           1,162
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-22477 Filed 9-30-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>